BIOLASE, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 9 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-12-10: Reporting owner TALEVICH JAMES R; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-12-10: Reporting owner LOW SAMUEL BERNARD; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-06-07: Reporting owner ENRIGHT ERIN S.; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-06-07: Reporting owner MOLL FREDERIC H; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-12-10 | TALEVICH JAMES R Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +27,500 27,500 owned after | $1.73 exercise price | 2013-12-20 | |
| 2013-12-10 | LOW SAMUEL BERNARD Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +27,500 27,500 owned after | $1.73 exercise price | 2013-12-20 | |
| 2013-06-07 | ENRIGHT ERIN S. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,000 35,000 owned after | $4.07 exercise price | 2013-06-14 | |
| 2013-06-07 | MOLL FREDERIC H Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,000 35,000 owned after | $4.07 exercise price | 2013-06-11 | |
| 2013-06-07 | MOLL FREDERIC H Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,250 57,250 owned after | $4.07 exercise price | 2013-06-11 | |
| 2013-06-06 | Arrow Alexander K. Director, Officer (President and COO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +350,000 474,500 owned after | $4.00 exercise price | 2013-06-11 | |
| 2013-06-06 | Nemoy Norman J. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 153,500 owned after | $4.00 exercise price | 2013-06-10 | |
| 2013-06-06 | LICHTWARDT GREGORY Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 130,750 owned after | $4.00 exercise price | 2013-06-10 | |
| 2013-03-23 | Furry Frederick D. Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 247,500 owned after | $5.00 exercise price | 2013-03-26 |